1,494
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Focus on cardiometabolic risk factors

References

  • Jorissen W, Annemans L, Louis N, et al. Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with canagliflozin in Belgium. Acta Clin Belg. 2022;77(6):945–954. doi: 10.1080/17843286.2021.2015554.
  • Leiter LA, Fitchett DH, Gilbert RE, et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol. 2011;27(2):e1–e33. doi: 10.1016/j.cjca.2010.12.054.
  • Lancellotti P, Cosyns B. Highlights of acta cardiologica. Acta Cardiol. 2022;77(6):469–470. doi: 10.1080/00015385.2022.2143092.
  • Menotti A, Puddu PE, Catasta G. Lifestyle behaviors predicting major cardiovascular diseases mortality in a practically extinct cohort of Middle-aged men followed-up for 61 years. Acta Cardiol. 2023;78(5):578–585. doi: 10.1080/00015385.2022.2101876.
  • Ebrahimi H, Shayestefar M, Talebi SS, et al. Prevalence of hypertension and its associated factors among professional drivers: a population-based study. Acta Cardiol. 2023;78(5):543–551. doi: 10.1080/00015385.2022.2045753.
  • Stremmel C, Vdovin N, Kellnar A, et al. Impact of moderate altitude exposure on cardiovascular risk. Acta Cardiol. 2021;16:1–4. doi: 10.1080/00015385.2021.1976449.
  • Prosecky R, Kunzova S, Kovacovicova P, et al. Association of anthropometric and body composition parameters with the presence of hypertension in the central european population: results from KardioVize 2030 study. Acta Cardiol. 2023;78(5):614–622. doi: 10.1080/00015385.2023.2192153.
  • Humbert X, Licaj I, Fedrizzi S, et al. Relationship between lifestyle factors and hypertension: a cross-sectional analysis from the gubbio study. Acta Cardiol. 2023;78(5):565–573. doi: 10.1080/00015385.2022.2088170.
  • Vynckier P, De Sutter J, De Pauw M, et al. Gender differences in risk factor management and pharmacological treatment among CHD patients: belgian results of the EUROASPIRE IV and EUROASPIRE V surveys. Acta Cardiol. 2023;78(5):607–613. doi: 10.1080/00015385.2023.2169439.
  • Şaylık F, Akbulut T. Temporal relationship between serum calcium and triglyceride-glucose index and its impact on the incident of the acute coronary syndrome: a cross-lagged panel study. Acta Cardiol. 2023;78(5):586–593. doi: 10.1080/00015385.2022.2106017.
  • Li H, Wei Y, Xi Y, et al. DR1-CSE/H2S pathway upregulates autophagy and inhibits H9C2 cells damage induced by high glucose. Acta Cardiol. 2023;78(5):594–606. doi: 10.1080/00015385.2022.2119663.
  • Cheng X, Li Z, Yang M, et al. Association of HbA1c with carotid artery plaques in patients with coronary heart disease. Acta Cardiol. 2022;31:1–9.
  • Sprynger M, Lancellotti P. Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease. Acta Cardiol. 2023;78(5):635–636.
  • Krohn JB, Neubauer C, Fischer S, et al. Optimisation of individual cardiovascular risk assessment in a german coronary artery disease cohort using a commercial test for genetic polymorphisms - a pilot study. Acta Cardiol. 2022;3:1–11.
  • Mungmunpuntipantip R, Wiwanitkit V. Comment on optimisation of individual cardiovascular risk assessment using a commercial test for genetic polymorphisms. Acta Cardiol. 2023;78(5):634. doi: 10.1080/00015385.2022.2135239.
  • Deconinck A, Morra S, Glassée N, et al. Value of repeated measurements of lipoprotein (a) to assess cardiovascular risk: a retrospective study. Acta Cardiol. 2023;78(5):536–542. doi: 10.1080/00015385.2022.2031377.
  • van de Borne P, Peeters A, Leone A, et al. Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study. Acta Cardiol. 2022;20:1–10. doi: 10.1080/00015385.2022.2030568.
  • Martens P, Mathieu C, Vanassche T. The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice. Acta Cardiol. 2023;78(5):552–564. doi: 10.1080/00015385.2022.2076307.
  • Boulmpou A, Patoulias D, Papadopoulos CE, et al. Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias. Acta Cardiol. 2023;78(5):519–524. doi: 10.1080/00015385.2022.2087839.
  • Nagarajan G, Govindan R, Poomarimuthu M, et al. The microbiome and rheumatic heart disease: current knowledge and future perspectives. Acta Cardiol. 2023;78(5):525–533. doi: 10.1080/00015385.2023.2207933.
  • Köseoğlu C, Ramazan Öncel C. Possible effects of subclinical hypothyroidism on right ventricular myocardial work parameters. Acta Cardiol. 2023;78(5):637. doi: 10.1080/00015385.2023.2214405.
  • Yurdam FS, Gürses E. Myocardial bridge and beta blockers: effect on left ventricular strain parameters. Acta Cardiol. 2023;78(5):623–629. doi: 10.1080/00015385.2023.2209421.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.